Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2296
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials ; volume:1 ; number:1 ; day:29 ; month:9 ; year:2000 ; pages:1-10 ; date:12.2000
BMC family practice ; 1, Heft 1 (29.9.2000), 1-10, 12.2000
- Urheber
-
Moore, R Andrew
- Beteiligte Personen und Organisationen
-
Wiffen, Philip J.
Lipsky, Benjamin A.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2296-1-1
- URN
-
urn:nbn:de:1111-201602184888
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Moore, R Andrew
- Wiffen, Philip J.
- Lipsky, Benjamin A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
The effect of age on the response to the pneumococcal polysaccharide vaccine
Adult Otogenic Meningitis in the Pneumococcal Conjugated Vaccines Era
Distinct baseline immune characteristics associated with responses to conjugated and unconjugated pneumococcal polysaccharide vaccines in older adults
Strengths and weaknesses of pneumococcal conjugate vaccines
Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus
Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis
An evaluation of emerging vaccines for childhood pneumococcal pneumonia
Impact of pneumococcal conjugate vaccines on invasive pneumococcal disease-causing lineages among South African children
Maternal vaccination for the protection of the newborn with pneumococcal polysaccharide vaccine in Gambia, West Africa
Effect of 23-valent pneumococcal polysaccharide vaccine on medical expenses in Japan
Effectiveness of the polysaccharide pneumococcal vaccine among HIV-infected persons in Brazil: a case control study
The effect of age on the response to the pneumococcal polysaccharide vaccine
Adult Otogenic Meningitis in the Pneumococcal Conjugated Vaccines Era
Distinct baseline immune characteristics associated with responses to conjugated and unconjugated pneumococcal polysaccharide vaccines in older adults
Strengths and weaknesses of pneumococcal conjugate vaccines
Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus
Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis
An evaluation of emerging vaccines for childhood pneumococcal pneumonia
Impact of pneumococcal conjugate vaccines on invasive pneumococcal disease-causing lineages among South African children
Maternal vaccination for the protection of the newborn with pneumococcal polysaccharide vaccine in Gambia, West Africa
Effect of 23-valent pneumococcal polysaccharide vaccine on medical expenses in Japan
Effectiveness of the polysaccharide pneumococcal vaccine among HIV-infected persons in Brazil: a case control study
The effect of age on the response to the pneumococcal polysaccharide vaccine
Adult Otogenic Meningitis in the Pneumococcal Conjugated Vaccines Era
Distinct baseline immune characteristics associated with responses to conjugated and unconjugated pneumococcal polysaccharide vaccines in older adults
Strengths and weaknesses of pneumococcal conjugate vaccines
Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus
Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis
An evaluation of emerging vaccines for childhood pneumococcal pneumonia
Impact of pneumococcal conjugate vaccines on invasive pneumococcal disease-causing lineages among South African children
Maternal vaccination for the protection of the newborn with pneumococcal polysaccharide vaccine in Gambia, West Africa
Effect of 23-valent pneumococcal polysaccharide vaccine on medical expenses in Japan